demonstrated that Roseburia intestinalis protects against CRC formation by producing butyrate, thereby enhancing the effectiveness of anti-Programmed death protein 1 (PD1) immunotherapy (28) (Figure 1, Table 1). This evidence concerns the gene PDCD1 and colorectal carcinoma.